Search is Powered by Google
Cancer / Oncology News

Blacks Older Than Age 65 Less Likely Than Whites To Receive Recommended Cancer Treatments, Study Finds

Main Category: Cancer / Oncology
Also Included In: Seniors / Aging
Article Date: 08 Jan 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Racial disparities persist in cancer treatment with black patients older than 65 "consistently less likely" than their white counterparts to receive the recommended treatment, according to a study published on Monday in the journal Cancer, Reuters reports. For the study, Yale University School of Medicine researchers examined cancer treatment for more than 143,000 U.S. residents with lung, breast, colon, rectal or prostate cancer who were treated from 1992 to 2002 under Medicare.

The largest disparities were seen in treatment of lung, colon and rectal cancers, according to the study. Researchers found that among people with early-stage lung cancer, blacks were 19% less likely to have tumors surgically removed than whites. Blacks with rectal cancer were 27% less likely than whites to undergo additional chemotherapy after having a tumor surgically removed, and blacks with colon cancer were 24% less likely to receive chemotherapy than whites after surgical removal of a tumor, according to the study. Among those with breast cancer who had a lumpectomy, blacks were 7% less likely than whites to get radiation therapy. Black men diagnosed with prostate cancer were 11% less likely than whites to receive surgical or radiation treatment, the study found.

Lead researcher Cary Gross said, "What we found was that racial disparities did not change during that 10-year time interval." Gross said possible factors for the disparities were blacks having less access to care; higher rates of certain chronic conditions among blacks, which can complicate cancer therapy; and distrust of the medical establishment among blacks.

Otis Brawley, chief medical officer of the American Cancer Society, said, "This sort of thing has been a problem in the United States for a long, long time," adding, "I think individual racism likely accounts for a small amount of it, but not a large amount. What I would refer to as institutional or societal racism accounts for a much larger component of it" (Dunham, Reuters, 1/7).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...